INFORM2 NivEnt: the first trial of the INFORM2 biomarker driven phase I/II trial series : the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies - Tilburg, Cornelis M. van; Witt, Ruth; Heiss, Melanie; Pajtler, Kristian Wilfried; Plass, Christoph; Poschke, Isabel; Platten, Michael; Harting, Inga; Sedlaczek, Oliver; Freitag, Angelika; Meyrath, David; Taylor, Lenka A.; et al. (BMC cancer, 2020)
Gesehen am 10.06.2021